Odisha has attracted ₹7,043 crore in investment commitments and intents across pharmaceuticals, medical technology and related manufacturing at the recently concluded Odisha Pharma Summit 2025 in Bhubaneswar. The summit, organised by the state government in partnership with industry bodies, brought together investors, policy makers and healthcare innovators to position the state as an emerging destination for life sciences investment. 

At the event, a total of 45 memoranda of understanding (MoUs) were signed, representing ₹6,263 crore in confirmed commitments with additional ₹780 crore in investment intents also announced. The deals span pharmaceutical formulations and bulk drugs, medical devices and tech manufacturing, and industrial infrastructure including dedicated parks for pharma and medtech projects. 

In detail, 32 MoUs in the pharmaceuticals sector accounted for proposed investments of around ₹2,681 crore, expected to generate thousands of jobs. The medical technology and devices segment accounted for another ₹582 crore, with prospective employment opportunities. A single major MoU for a medical-industrial park brought in a ₹3,000 crore commitment, projected to create tens of thousands of jobs once operational.

Chief Minister Mohan Charan Majhi underscored the state’s push to attract sustained investment in life sciences by offering policy incentives, robust infrastructure and a skilled workforce. The strategic mobilisation of capital and industry participation reflects Odisha’s broader ambition to align with Make in India and Atmanirbhar Bharat goals while creating a competitive, innovation-oriented healthcare manufacturing ecosystem.